JNJ beat Q4 earnings and sales estimates ... how to play J&J’s stock in the post-earnings scenario. J&J’s Innovative Medicine unit is showing a growing trend. The segment’s sales rose ...

The Drexel Drug Discovery and Development (4D) Fellowship Program is a joint effort between Johnson & Johnson Innovative Medicine and Drexel’s Pharmacology and Physiology Department to support ...

Kevin Hamill, President, U.S. Immunology, Johnson & Johnson Innovative Medicine “The reality is that only about 10% of patients today living with immune-mediated diseases are achieving remission ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial public offering as early as this year, Amber Tong ...

Omega Healthcare Investors Inc.-3.88% $10.16B ...

Before Stryker, Wells had 17 years of senior accounting and financial management experience, holding finance leadership roles at Dialight Corporation and Johnson & Johnson. He graduated from Bucknell ...